title: Physiology and pathophysiology of liver lipid metabolism.
abstract: Liver lipid metabolism and its modulation are involved in many pathologic conditions, such as obesity, non-alcoholic fatty liver disease, diabetes mellitus, atherosclerosis and cardiovascular disease. Metabolic disorders seem to share a similar background of low-grade chronic inflammation, even if the pathophysiological mechanisms leading to tissue and organ damage have not been completely clarified yet. The accumulation of neutral lipids in the liver is now recognized as a beneficial and protective mechanism; on the other hand, lipoperoxidation is involved in the development and progression of non-alcoholic steatohepatitis. The role of the gut microbiota in liver lipid metabolism has been the object of recent scientific investigations. It is likely that the gut microbiota is involved in a complex metabolic modulation and the translocation of gut microflora may also contribute to maintaining the low-grade inflammatory status of metabolic syndrome. Therefore, lipid metabolism pathology has vague limits and complex mechanisms, and the knowledge of these is essential to guide diagnostic and therapeutic decisions.
authors.affiliation: Internal Medicine and Gastroenterology, Agostino Gemelli Hospital, Rome, Italy.
authors.forename: Francesca Romana
authors.initials: FR
authors.lastname: Ponziani
authors.forename: Silvia
authors.initials: S
authors.lastname: Pecere
authors.forename: Antonio
authors.initials: A
authors.lastname: Gasbarrini
authors.forename: Veronica
authors.initials: V
authors.lastname: Ojetti
mesh_terms: D000818:Animals; D017209:Apoptosis; D000069196:Gastrointestinal Microbiome / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D008053:Lipid Mobilization; D008099:Liver / Q000378:metabolism* / Q000503:physiopathology; D065626:Non-alcoholic Fatty Liver Disease / Q000378:metabolism*
keywords: NAFLD; NASH; cardiovascular disease; cholesterol; gut microbiota; liver lipid metabolism; metabolic syndrome